Issue 11/2010
Content (29 Articles)
Ageing brain abnormalities in young obese patients with type 2 diabetes: a cause for concern
J. J. Nolan
Hypoglycaemia following gastric bypass surgery—diabetes remission in the extreme?
M. E. Patti, A. B. Goldfine
Genetic variants affecting incretin sensitivity and incretin secretion
K. Müssig, H. Staiger, F. Machicao, H.-U. Häring, A. Fritsche
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus
P. L. Yau, D. C. Javier, C. M. Ryan, W. H. Tsui, B. A. Ardekani, S. Ten, A. Convit
Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden
R. Marsk, E. Jonas, F. Rasmussen, E. Näslund
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study
T. J. Orchard, A. M. Secrest, R. G. Miller, T. Costacou
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Q. Li, J. Chalmers, S. Czernichow, B. Neal, B. A. Taylor, S. Zoungas, N. Poulter, M. Woodward, A. Patel, B. de Galan, G. D. Batty
HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
M. V. Skriver, K. Borch-Johnsen, T. Lauritzen, A. Sandbaek
Expression analysis of loci associated with type 2 diabetes in human tissues
C. Cotsapas, L. Prokunina-Olsson, C. Welch, R. Saxena, C. Weaver, N. Usher, C. Guiducci, S. Bonakdar, N. Turner, B. LaCroix, J. L. Hall
Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo
J. Zhao, J. Schug, M. Li, K. H. Kaestner, S. F. A. Grant
Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes
L. E. Docherty, R. L. Poole, C. J. Mattocks, A. Lehmann, I. K. Temple, D. J. G. Mackay
A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse
A. Hugill, K. Shimomura, F. M. Ashcroft, R. D. Cox
Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients
U. Pugazhenthi, K. Velmurugan, A. Tran, G. Mahaffey, S. Pugazhenthi
Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass
G. Fontés, B. Zarrouki, D. K. Hagman, M. G. Latour, M. Semache, V. Roskens, P. C. Moore, M. Prentki, C. J. Rhodes, T. L. Jetton, V. Poitout
Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult rat pancreas
M. Chintinne, G. Stangé, B. Denys, P. In ‘t Veld, K. Hellemans, M. Pipeleers-Marichal, Z. Ling, D. Pipeleers
Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation
S. H. Huang, C. H. Chu, J. C. Yu, W. C. Chuang, G. J. Lin, P. L. Chen, F. C. Chou, L. Y. Chau, H. K. Sytwu
Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditions
F. A. J. L. Scheer, J. L. Chan, J. Fargnoli, J. Chamberland, K. Arampatzi, S. A. Shea, G. L. Blackburn, C. S. Mantzoros
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
A. Nerstedt, A. Johansson, C. X. Andersson, E. Cansby, U. Smith, M. Mahlapuu
Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse
S. Muñoz, S. Franckhauser, I. Elias, T. Ferré, A. Hidalgo, A. M. Monteys, M. Molas, S. Cerdán, A. Pujol, J. Ruberte, F. Bosch
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
V. B. Matthews, T. L. Allen, S. Risis, M. H. S. Chan, D. C. Henstridge, N. Watson, L. A. Zaffino, J. R. Babb, J. Boon, P. J. Meikle, J. B. Jowett, M. J. Watt, J.-O. Jansson, C. R. Bruce, M. A. Febbraio
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
K. C. Sourris, A. L. Morley, A. Koitka, P. Samuel, M. T. Coughlan, S. A. Penfold, M. C. Thomas, A. Bierhaus, P. P. Nawroth, H. Yamamoto, T. J. Allen, T. Walther, T. Hussain, M. E. Cooper, J. M. Forbes
Posthumous Caesarean section in women with type 1 diabetes mellitus: two cases at one hospital in northern India
B. Kalra, S. Kalra, B. Chhabra
Multidrug therapy in a patient with Rabson–Mendenhall syndrome
Rodrigo O. Moreira, R. L. Zagury, T. S. Nascimento, L. Zagury
Cholesterol toxicity in pancreatic islets from LDL receptor-deficient mice
J. C. de Souza, C. A. M. de Oliveira, E. M. Carneiro, A. C. Boschero, H. C. F. de Oliveira
Cholesterol toxicity in pancreatic islets from LDL receptor-deficient mice. Reply to: de Souza JC, de Oliveira CAM, Carneiro EM et al. [letter]
J. K. Kruit, L. R. Brunham, C. B. Verchere, M. R. Hayden